Phenol

Phenol

SCHEMBL8029599

OCC(CO)(CO)CO.Oc1ccccc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.61
CA2 P00918 3/20 0.61
CA9 Q16790 3/20 0.61
CA14 Q9ULX7 3/20 0.61
CA1 P00915 2/20 0.61
CA3 P07451 2/20 0.61
CA4 P22748 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
GLA P06280 1/20 0.61
MMP3 P08254 1/20 0.43
BCL2L1 Q07817 1/20 0.43
ESR1 P03372 5/20 0.41
ESR2 Q92731 5/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP3A4 P08684 3/20 0.41
TSHR P16473 1/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
KMT2A Q03164 2/20 0.39
LTA4H P09960 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenol SCHEMBL10790520 1.00 CA12 (0.61) CA12CA2CA9CA14CA1
Phenol SCHEMBL8854476 0.93 CA12 (0.52) CA12CA2CA9CA14CA1
Phenol SCHEMBL1458360 0.89 CA2 (0.48) CA12CA2CA9CA14CA1
Phenol SCHEMBL11884155 0.89 TDP1 (0.48) CA12CA2CA9CA14CA1
Biphenyl SCHEMBL3688776 0.80 ALDH1A1 (0.53) CA2CA1TDP1MMP3BCL2L1
Phenol SCHEMBL4107850 0.79 CA2 (0.73) CA12CA2CA9CA14CA1
Phenol SCHEMBL1414513 0.79 CA2 (0.73) CA12CA2CA9CA14CA1
Phenol SCHEMBL11351307 0.79 CA12 (0.55) CA12CA2CA9CA14CA1
Phenol SCHEMBL9499327 0.79 CA12 (0.55) CA12CA2CA9CA14CA1
Tromethamine SCHEMBL218955 0.79 CA12 (0.55) CA12CA2CA9CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0151763-A2 Stabilized fluoropolymer composition ALLIED CORPORATION (US) 1985-08-21 EP claimed
US-4496677-A A HINDERED PHENOL PENTAERYTHRIOL DIPHOSPHITE AND A GROUP 22 SALT OF CARBOXYLIC ACID ALLIED CORPORATION (US) 1985-01-29 US claimed
US-20230133549-A1 VIRAL INFECTIONS - TREATMENT WITH CONVALESCENT PLASMA/SERUM REGEN LAB USA LLC (US) 2023-05-04 US disclosed
EP-4114526-A1 VIRAL INFECTIONS- TREATMENT WITH CONVALESCENT PLASMA/SERUM Regen Lab SA (CH) 2023-01-11 EP disclosed
WO-2021198312-A1 VIRAL INFECTIONS- TREATMENT WITH CONVALESCENT PLASMA/SERUM REGEN LAB SA (CH) 2021-10-07 WO disclosed
CN-107614556-A Acrylic block copolymer and the resin combination, formed body and optical component for including it 株式会社可乐丽 2018-01-19 CN disclosed
CN-104004017-B Diphenylphosphine cumyl phenolic ester and synthetic method thereof 青岛职业技术学院 2017-02-01 CN disclosed
CN-104004017-A Diphenylphosphine cumyl phenolic ester and synthetic method thereof QINGDAO TECHNICAL COLLEGE 2014-08-27 CN disclosed
EP-0885877-B1 Process for hydrogenation of cyanopropionaldehyde-containing cyanopropionaldehyde acetals AIR PROD & CHEM (US) 2000-04-12 EP disclosed
EP-0885877-A1 Process for hydrogenation of cyanopropionaldehyde-containing cyanopropionaldehyde acetals AIR PRODUCTS AND CHEMICALS, INC. (US) 1998-12-23 EP disclosed
US-5847220-A Process for hydrogenation of cyanopropionaldehyde-containing cyanopropionaldehyde acetals AIR PRODUCTS AND CHEMICALS, INC. (US) 1998-12-08 US disclosed
US-4888371-A HEAT RESISTANCE, LIGHT RESISTANCE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1989-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133549-A1 VIRAL INFECTIONS - TREATMENT WITH CONVALESCENT PLASMA/SERUM SERPINA6, CD4, TTPA CA12 4122/4885CA2 4676/4885CA9 4262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.